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values were extracted and multiple regression was carried out. 
Variables analysed were: cylinder angle placement related to the 
craneo-caudal patient axis, rectum volume, cylinder diameter, type of 
rectal content. 
Results: Rectum volume had a significant association (p<.0001) with 
the type of rectal content. Multiple linear regression model found 
cylinder angle position, rectal volume, type of rectal content and 
cylinder diameter as the significant variables related to high rectum 
DVH dose values analysed (table). Cylinders pointing toward rectum, 
large rectum volumes, air and contrast taking part of the rectal 
content and the use of small cylinders were related to high dose 
values. 
 
 Conclusions: Despite vaginal cuff brachytherapy is a well settled 
procedure, a little way of improvement could be achieved taking care 
of the thecnique procedure; from our results, cleaning the rectum 
prior to the procedure could be one among them. 
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Purpose/Objective: This study aimed to determine the current 
application of image-guided brachytherapy (IGBT) for patients with 
uterine cervical cancer in Japan. 
Materials and Methods: In July 2012, questionnaires were sent to 171 
Japanese centers identified as having a high-dose rate (HDR) 
brachytherapy machine. The questionnaire consisted of 28 items 
regarding current practice patterns and future plans for IGBT for 
patients with cervical cancer. 
Results: Responses were received from 144 (84%) centers. Only 2% of 
the centers used ultrasound guidance routinely for applicator 
insertion, and 24% used it occasionally. Images obtained after 
applicator insertion were orthogonal X-rays (XP) alone in 59%, XP and 
CT in 28%, XP and CT and MRI in 1%, and CT/MRI without XP in 6%. MRI 
was obtained in only 2% of the centers. 3D planning for actual 
treatment was performed in 15% of the centers, while 35% performed 
CT/MRI with the applicators in place. Reasons the remaining 20% of 
the centers did not perform 3D planning for actual treatment (use 2D 
planning data with XP alone) were: limited physician time (72%), 
limited number of staff members (48%), insufficient planning software 
(31%), unproven benefit (3%) and insufficient knowledge/training in 3D 
planning (24%). CT/MRI-compatible applicators were utilized in 22% of 
the centers where the CT/MRI were acquired. The technical details of 
IGBT were analyzed for 22 centers performing the 3D planning for 
actual treatment. Contouring of organs at risk was done for the 
rectum in the 73% of the centers, for the bladder in 68%, for the 
sigmoid colon in 45%, and for the small intestine in 41%. Regarding 
target volumes, GTV-BT was contoured in 23% of the centers, HR-CTV 
in 45%, and IR-CTV in 14%. Doses were prescribed to point A alone in 
55% of the centers, point A and HR-CTV in 41%, and HR-CTV alone in 
0%. Applicator reconstruction was performed by radiation 
technologists (RT) in 68% of the centers and radiation oncologists (RO) 
in 32%. Contouring was mainly done by the RO (95%). Dose calculation 
was done by the RO (86%) and the RT (72%). Medical physicist 
involvement in these processes was limited: 9% of the centers for 
applicator construction, 9% for contouring, and 14% for dose 
calculation. Fifty-five percent of the centers where 3D planning is 
currently withheld hope to implement it for actual treatment. 
Conclusions: Although over 1/3 of the centers obtained CT images 
after applicator insertion, the use of 3D treatment planning remains 
limited in Japan.  
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Purpose/Objective: In brachytherapy also image-guidance plays an 
important role. For GYN treatments it is standard to acquire CT 
images and preferably also MR images prior to each treatment to 
calculate the dose of the day. The dose of the complete treatment is 
calculated by adding the dose metrics of each fraction e.g. V100 for 
target and D0.1cc or D2cc for OAR. It makes the safe conservative but 
incorrect assumption that the same part of the OAR always receives 
the highest dose. The dose calculated this way often limits the 
prescription dose or the target coverage. We investigate an 
alternative method to assess the cumulative dose for a treatment 
course; the use of deformable image registration (DIR) software to 
track the deformations of the OAR due to the bladder and rectum 
filling as well as by the insertion of the applicator. 
Materials and Methods: CT images are acquired during each fraction. 
Rigid registration is preformed, followed by DIR. DIR can be either 
based only on the 3D images or partially on the 3D images and on the 
organ contours. One of the problems in the pelvic region is the lack of 
contrast between structures in CT images that makes it difficult for 
DIR based on images alone. We investigated two possible solutions: (1) 
the use of CT images combined with contours (2) the use of the CT 
image modified to artificially increase the contrast in certain 
volumes.We use two optical flow deformation algorithms in parallel: a 
morphon algorithm or a demon algorithm to match the images and a 
demons algorithm applied to distance maps computed from the 
contours. The dose matrix from day2 exported from a treatment 
planning is deformed using the calculated deformation field in our 
software. We also use in-house software to generate CT images for 
simulations studies. 
Results: The first results on dose accumulation (fig 1) are based on 
contrast-enhanced CT images or the original CT image with the 
bladder contours as constraint. The use of the contrast-enhanced 
images helps to guide the DIR more than the use of the contours as 
shown by the higher DICE indices. Even for good contour matching, a 
small local error in the deformation can have significant consequences 
for the dose distribution, resulting in our example in dose metrics 
exceeding the ones calculated using the GEC-ESTRO recommendation, 
which is unphysical. 
  
Conclusions: Using DIR based on image features and contours,we 
 
